Therapy of chronic hepatitis B: new goals and new treatments.

Abstract

Treatment of chronic hepatitis B has shown a rapid development in the last years leading to a shift of treatment strategies from interferon to hepatitis B virus (HBV)-polymerase inhibitors. In particular, treatment with HBV-polymerase inhibitors has changed the indication on how to treat a patient and when to stop therapy. Long-term treatment with HBV-polymerase inhibitors may often be required, even if it raises the possibility of resistance and subsequent treatment failure. This review provides a strategy on how to manage HBV therapy with the currently available treatment options.

Cite this paper

@article{Mauss2009TherapyOC, title={Therapy of chronic hepatitis B: new goals and new treatments.}, author={Stefan Mauss}, journal={Minerva medica}, year={2009}, volume={100 6}, pages={447-58} }